David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly
In his new role, Kendall will serve as a senior medical advisor for Lilly Diabetes in advocacy and clinical science communities and as a representative to the professional medical community. In addition, he will help provide scientific direction for Lilly in diabetes discovery and clinical development. Other key responsibilities will include the support of Lilly's medical education efforts and diabetes healthcare evaluation programs.
"David brings a critical external view, including the insights he gained while at the
Kendall will report to
"With his background as a clinician, researcher and diabetes advocate, David is the ideal candidate for this position," said Heine. "His focus, passion and understanding of diabetes care will enable us to create ever better solutions for people living with diabetes."
About
Kendall joins Lilly Diabetes from the
Kendall also is an associate professor of medicine at the
Prior to these appointments, Kendall held a number of leadership positions at the
Kendall's experience in diabetes spans nearly 25 years, with a research focus on the clinical management of type 1 and type 2 diabetes, emerging novel therapies as well as the treatment and prevention of diabetes complications. He is the author of more than 150 original manuscripts, chapters and professional reviews and a former NIH clinical investigator for both the
Kendall received his bachelor's degree from
About Lilly Diabetes
For more than 85 years, Lilly has been a worldwide leader in pioneering industry-leading solutions to support people living with and treating diabetes. Lilly introduced the world's first commercial insulin in 1923, and remains at the forefront of medical and delivery device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy - practical tools, education, and support programs to help overcome barriers to success along the diabetes journey. At Lilly, the journeys of each person living with or treating diabetes inspire ours. For more information, visit www.lillydiabetes.com.
About
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in
P-LLY
(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )
SOURCE
News Provided by Acquire Media